Ready to plan your post-weight-loss body contouring
As Shreehas Tambe, Chief Executive Officer and Managing Director of Biocon Biologics Limited, noted regarding demand and growth potential for GLP-1 therapies, There will be a requirement for significantly higher volumes and Biocons fermentation capability will give us a significant advantage. India leads with a CAGR of 8.4%, driven by a large diabetic population and increasing demand for effective treatments
Patients 13 and older diagnosed with severe obesity should be evaluated for bariatric surgery, the authors wrote
Thats why working with a provider trained in obesity medicine is keythey can guide your next steps, provide ongoing support, and monitor your outcomes closely
The half-life of semaglutide is approximately 168 hours
[2] Centrally, these medications act on appetite-regulating centres in the hypothalamus, leading to reduced caloric intake and subsequent weight loss